Researchmoz added Most up-to-date research on "Global Nucleic Acid Testing Market 2016-2020" to its huge collection of research reports.
Nucleic acid testing (NAT) is the process involved in the detection of viral DNAs and RNAs in blood samples of individuals. NAT or nucleic acid amplification test (NAAT) is one of the fastest growing segments in the in-vitro diagnostics market (IVD). There are different types of NAT techniques such as Polymerase chain reaction (PCR), Strand displacement amplification (SDA), Ligase chain reaction (LCR), Transcription-mediated amplification (TMA), Nucleic acid sequence based amplification (NASBA) and whole genome sequencing.
Technavios analysts forecast the global nucleic acid testing market to grow at a CAGR of 9.96% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global nucleic acid testing market for 2016-2020. To calculate the market size, the report presents the vendor landscape and a corresponding detailed analysis of the top vendors operating in the market.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=892993
Technavio's report, Global Nucleic Acid Testing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
Abbott Laboratories
Roche Molecular Systems
Siemens Healthineers
Hologic
Qiagen
Other prominent vendors
Accriva Diagnostics
Acon Laboratories
Affymetrix
Ahram Biosystem
Asuragen
Biocartis
Bio-Rad Laboratories
Cepheid
DiagCor
EKF Diagnostics
Erba Diagnostics
Randox Laboratories
Market driver
Higher adoption rate of molecular point-of-care (POC) testing.
For a full, detailed list, view our report
Market challenge
Risks associated with molecular diagnosis.
For a full, detailed list, view our report
Market trend
Advances in precision and personalized medicine.
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=892993
Nucleic acid testing (NAT) is the process involved in the detection of viral DNAs and RNAs in blood samples of individuals. NAT or nucleic acid amplification test (NAAT) is one of the fastest growing segments in the in-vitro diagnostics market (IVD). There are different types of NAT techniques such as Polymerase chain reaction (PCR), Strand displacement amplification (SDA), Ligase chain reaction (LCR), Transcription-mediated amplification (TMA), Nucleic acid sequence based amplification (NASBA) and whole genome sequencing.
Technavios analysts forecast the global nucleic acid testing market to grow at a CAGR of 9.96% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global nucleic acid testing market for 2016-2020. To calculate the market size, the report presents the vendor landscape and a corresponding detailed analysis of the top vendors operating in the market.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=892993
Technavio's report, Global Nucleic Acid Testing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
Abbott Laboratories
Roche Molecular Systems
Siemens Healthineers
Hologic
Qiagen
Other prominent vendors
Accriva Diagnostics
Acon Laboratories
Affymetrix
Ahram Biosystem
Asuragen
Biocartis
Bio-Rad Laboratories
Cepheid
DiagCor
EKF Diagnostics
Erba Diagnostics
Randox Laboratories
Market driver
Higher adoption rate of molecular point-of-care (POC) testing.
For a full, detailed list, view our report
Market challenge
Risks associated with molecular diagnosis.
For a full, detailed list, view our report
Market trend
Advances in precision and personalized medicine.
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=892993
No comments:
Post a Comment